REGN•benzinga•
Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $1126
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 1, 2024 by benzinga